XML 25 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues and other:      
Sales $ 826,455 $ 755,290 $ 826,324
Nonoperating Income (Expense) 20,376 (67,294) 28,371
Total revenues, net of other expenses 846,831 687,996 854,695
Costs and expenses:      
Cost of Goods and Services Sold 649,690 558,967 641,140
Selling, general and administrative 74,964 84,246 76,598
Research and development 6,347 8,398 7,893
Amortization of identifiable intangibles 1,704 3,017 13,601
Accrued pension and postretirement benefits 14,160 14,720 9,642
Interest expense 3,386 2,587 4,051
Asset impairments and costs associated with exit and disposal activities, net of adjustments 1,127 1,725 784
Goodwill, Impairment Loss 0 13,696 0
Total 779,610 713,042 782,689
Income (loss) from continuing operations before income taxes 67,221 (25,046) 72,006
Income tax expense (benefit) [1] 9,284 (8,213) 13,545
Net income (loss) from continuing operations 57,937 (16,833) 58,461
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax (111) (58,611) (10,202)
Net income (loss) $ 57,826 $ (75,444) $ 48,259
Basic:      
Continuing operations (in usd per share) $ 1.72 $ (0.51) $ 1.76
Discontinued operations (in usd per share) 0 (1.75) (0.31)
Net income (in usd per share) 1.72 (2.26) 1.45
Diluted:      
Continuing operations (in usd per share) 1.72 (0.51) 1.76
Discontinued operations (in usd per share) 0 (1.75) (0.31)
Net income (in usd per share) $ 1.72 $ (2.26) $ 1.45
Weighted Average Number of Shares Issued, Basic 33,563 33,402 33,236
Weighted Average Number of Shares Outstanding, Basic and Diluted 33,670 33,402 33,258
Shipping and Handling [Member]      
Costs and expenses:      
Cost of Goods and Services Sold $ 28,232 $ 25,686 $ 28,980
Other Cost of Operating Revenue $ 28,232    
[1] See Notes 1, 9, 15, 16 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.